Magaldrato Teva (Magaldrate Anhydrous)

Magaldrate, the active ingredient in Magaldrato Teva, is an antacid presented as an oral dosage form for oral use. It neutralizes excess stomach acid and is used to relieve heartburn, acid indigestion, dyspepsia and gastro‑oesophageal reflux symptoms in adults and children.

GNH USA supplies Magaldrato Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and reliable delivery across global markets.

Magaldrato Teva, a gastrointestinal antacid, is employed to manage conditions related to excess gastric acidity.

- Heartburn: provides rapid relief by neutralizing stomach acid that irritates the esophagus. - Acid indigestion: reduces acidity that causes discomfort after meals. - Gastro‑oesophageal reflux symptoms: raises gastric pH to lessen reflux‑related irritation.

Magaldrato Teva may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Constipation: occasional hard stools or reduced bowel movements. - Diarrhoea: loose stools occurring after dosing. - Nausea: feeling of unease or urge to vomit. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Hypermagnesemia: elevated magnesium levels, potentially causing muscle weakness or cardiac effects. - Metabolic alkalosis: excessive rise in blood pH due to over‑neutralisation of acid.

When using Magaldrato Teva, consider the following precautions.

- Pregnancy: safety not established; use only if clearly needed. - Renal impairment: monitor magnesium load and avoid excessive dosing. - Aluminum accumulation: avoid prolonged use in patients with reduced renal clearance. - Drug interactions: separate administration from other oral medicines by at least two hours. - Hypersensitivity: discontinue if allergic reactions such as rash or swelling occur. - Store at ambient temperature: keep in the original container, protect from moisture.

Magaldrato Teva can affect the absorption or activity of several other medicines.

Major Interactions (Avoid): - Tetracycline antibiotics: antacid may markedly reduce antibiotic absorption. - Iron supplements: concurrent use can significantly decrease iron uptake.

Moderate Interactions (Monitor Closely): - Digoxin: antacid may increase serum digoxin concentrations. - Warfarin: possible alteration of anticoagulant effect, requiring INR monitoring. - Lithium: antacid may raise lithium levels, necessitating serum concentration checks.